United States Viscosupplementation Market Insights Forecasts to 2033

• The Market Size is growing at a CAGR of 7.5% from 2023 to 2033
• The US Viscosupplementation Market Size is Expected to Hold a Significant Share by 2033

The US Viscosupplementation Market Size is Anticipated to Hold a Significant Share by 2033, growing at a CAGR of 7.5% from 2023 to 2033.

Market Overview

Viscosupplementation is a medical treatment used to treat osteoarthritis, especially in the knee, with hyaluronic acid or its derivatives injected into the joint space. This procedure restores the synovial fluid's viscoelastic properties, improving the joint-lubricating function and pain and inflammation due to degenerative joint disease. Viscosupplementation is popularly used for patients who have moderate to severe osteoarthritis, in an attempt to avoid surgery that would be more invasive. Growth factors for the United States viscosupplementation market include the increasing incidence of osteoarthritis, mainly among the elderly, and rising interest in non-invasive treatments. With the aging population, the requirement for safe, low-risk interventions that can help manage joint pain and induce mobility is increasing day by day. Moreover, the rising perception of viscosupplementation as an alternative treatment choice and advanced formulations of hyaluronic acid have helped propel this market. Government efforts to increase access to healthcare and fund research into novel treatments for musculoskeletal disorders have further bolstered this market's growth. Such efforts, along with increasing healthcare expenditures and a steady upsurge in minimally invasive procedures, are expected to fuel the further growth of the viscosupplementation market in the United States.

Report Coverage

This research report categorizes the market for the United States viscosupplementation based on various segments and regions forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the United States viscosupplementation market. Recent market developments and competitive strategies such as expansion, product launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each United States viscosupplementation market sub-segment.

Driving Factors

The rise in the cases of osteoarthritis, mainly among the aging population, dictates a greater need for effective treatment options in the United States. Viscosupplementation is a non-surgical treatment that makes it an attractive option for patients preferring reduced-risk surgery. Developments have improved the formulation of hyaluronic acid in raising the efficacy and safety of viscosupplementation. Increased awareness of the treatment's benefits and the expanding availability of minimally invasive procedures fuel market growth. Favorable government initiatives supporting healthcare accessibility and research in musculoskeletal disorders also strengthen the expansion of the market.

Restraining Factors

The high cost of treatment, limited reimbursement options, and patient uncertainty regarding long-term efficacy in the United States viscosupplementation market could hamper growth. Further, the availability of other alternative treatments like corticosteroid injections and surgery may limit this market's growth.

Market Segment

The U.S.  viscosupplementation market share is classified into type and source.

• The multi-injection segment is expected to hold the largest market share through the forecast period.

The US viscosupplementation market is by type into single injection and multi-injection. Among these, the multi-injection segment is expected to hold the largest market share through the forecast period. This is attributed to the multi-injection viscosupplementation, which provides longer relief for patients with osteoarthritis and typically involves a series of injections over a few weeks. This is preferred as it ensures sustained efficacy in pain management and function in the joint, making it a popular choice among healthcare providers.

• The non-animal segment is expected to hold the largest market share through the forecast period.

The US viscosupplementation market is segmented by source into animal and non-animal. Among these, the non-animal segment is expected to hold the largest market share through the forecast period. This is attributed to the non-animal sources, particularly synthetic or recombinant hyaluronic acid, are gaining popularity due to their lower risk of allergic reactions and other complications associated with animal-derived products.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the United States viscosupplementation market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Zimmer Biomet
• Anika Therapeutics, Inc.
• Bioventus
• Biotech
• Ferring
• Sanofi
• APTISSEN
• Avanos Medical, Inc.
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts regional and country revenue from 2022 to 2033. Spherical Insights has segmented the United States viscosupplementation market based on the below-mentioned segments:

United States Viscosupplementation Market, By Type

• Single injection
• Multi injection

United States Viscosupplementation Market, By Source

• Animal
• Non-animal